1 November 2024 false No description of principal activity Taxfiler 2024.6 12578662business:PrivateLimitedCompanyLtd2024-11-012025-10-31 125786622024-10-31 12578662business:EntityHasNeverTraded2024-11-012025-10-31 125786622024-11-012025-10-31 12578662business:AuditExempt-NoAccountantsReport2024-11-012025-10-31 12578662business:FilletedAccounts2024-11-012025-10-31 125786622025-10-31 125786622024-10-31 12578662core:AfterOneYear2025-10-31 12578662core:AfterOneYear2024-10-31 12578662core:ShareCapitalcore:PreviouslyStatedAmount2025-10-31 12578662core:ShareCapitalcore:PreviouslyStatedAmount2024-10-31 12578662core:SharePremiumcore:PreviouslyStatedAmount2025-10-31 12578662core:SharePremiumcore:PreviouslyStatedAmount2024-10-31 12578662core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-10-31 12578662core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-10-31 12578662core:PreviouslyStatedAmount2025-10-31 12578662core:PreviouslyStatedAmount2024-10-31 12578662business:SmallEntities2024-11-012025-10-31 12578662business:Director12024-11-012025-10-31 12578662countries:EnglandWales2024-11-012025-10-31 12578662business:RegisteredOffice2024-11-012025-10-31 12578662business:OrdinaryShareClass12024-11-012025-10-31 12578662business:OrdinaryShareClass12023-11-012024-10-31 125786622023-11-012024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12578662 (England and Wales)
Malpapharm Holdings Ltd Unaudited accounts for the year ended 31 October 2025
Malpapharm Holdings Ltd Unaudited accounts Contents
Page
Statement of financial position
3
Notes to the accounts
4
- 2 -
Malpapharm Holdings Ltd Statement of financial position as at 31 October 2025
2025 
2024 
Notes
£ 
£ 
Called up share capital not paid
10 
10 
Fixed assets
Investments
4
724,958 
724,958 
Net current assets
- 
- 
Total assets less current liabilities
724,968 
724,968 
Creditors: amounts falling due after more than one year
5
(305,508)
(305,508)
Net assets
419,460 
419,460 
Capital and reserves
Called up share capital
6
10 
10 
Share premium
400,000 
400,000 
Profit and loss account
19,450 
19,450 
Shareholders' funds
419,460 
419,460 
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 15 July 2026 and were signed on its behalf by
Mr Malcolm Brown Director Company Registration No. 12578662
- 3 -
Malpapharm Holdings Ltd Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Malpapharm Holdings Ltd is a private company, limited by shares, registered in England and Wales, registration number 12578662. The registered office is 117 Atwood Road, Manchester, M20 6JW, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in shares are included at cost.
4
Investments
Subsidiary undertakings 
£ 
Valuation at 1 November 2024
724,958 
Valuation at 31 October 2025
724,958 
5
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Amounts owed to group undertakings and other participating interests
273,572 
305,508 
Loans from directors
31,936 
- 
305,508 
305,508 
6
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
1,000 Ordinary shares of £0.01 each
10 
10 
7
Transactions with related parties
Malpapharm Holdings Limited holds a 90% shareholding in Malpapharm Limited. At 31 October 2025, Malpapharm Holdings Limited owed Malpapharm Limited £273,572 (2024: £305,508). No interest is charged on the loan.
- 4 -
Malpapharm Holdings Ltd Notes to the Accounts for the year ended 31 October 2025
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -